Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 26 entries
Sorted by: Best Match Show Resources per page
Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?.

Mediterranean journal of rheumatology

Sachinidis A, Garyfallos A.
PMID: 34964023
Mediterr J Rheumatol. 2021 Sep 30;32(3):192-199. doi: 10.31138/mjr.32.3.192. eCollection 2021 Sep.

Double Negative (DN) B cells constitute a B cell population that lacks expression of immunoglobulin D and CD27 memory marker. These cells expand in elderly healthy individuals, but also accumulate prematurely in autoimmune and infectious diseases. COVID-19 is a...

Cite
Sachinidis A, Garyfallos A. Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?. Mediterr J Rheumatol. 2021;32(3):192-199doi: 10.31138/mjr.32.3.192.
Sachinidis, A., & Garyfallos, A. (2021). Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?. Mediterranean journal of rheumatology, 32(3), 192-199. https://doi.org/10.31138/mjr.32.3.192
Sachinidis, Athanasios, and Garyfallos, Alexandros. "Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?." Mediterranean journal of rheumatology vol. 32,3 (2021): 192-199. doi: https://doi.org/10.31138/mjr.32.3.192
Sachinidis A, Garyfallos A. Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?. Mediterr J Rheumatol. 2021 Sep 30;32(3):192-199. doi: 10.31138/mjr.32.3.192. eCollection 2021 Sep. PMID: 34964023; PMCID: PMC8693305.
Copy Download .nbib Format: NLM
Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review.

Case reports in oncological medicine

Husnain M, Kurtin S, Barkett N, Riaz IB, Agarwal A.
PMID: 27752376
Case Rep Oncol Med. 2016;2016:2490168. doi: 10.1155/2016/2490168. Epub 2016 Sep 26.

Patients with relapsed and refractory multiple myeloma have poor prognosis. A recent analysis of patients with relapsed and refractory multiple myeloma who were refractory to both proteasome inhibitors and immunomodulatory drugs showed the median overall survival of 9 months...

Cite
Husnain M, Kurtin S, Barkett N, et al. Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review. Case Rep Oncol Med. 2016;2016:2490168doi: 10.1155/2016/2490168.
Husnain, M., Kurtin, S., Barkett, N., Riaz, I. B., & Agarwal, A. (2016). Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review. Case reports in oncological medicine, 20162490168. https://doi.org/10.1155/2016/2490168
Husnain, Muhammad, et al. "Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review." Case reports in oncological medicine vol. 2016 (2016): 2490168. doi: https://doi.org/10.1155/2016/2490168
Husnain M, Kurtin S, Barkett N, Riaz IB, Agarwal A. Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review. Case Rep Oncol Med. 2016;2016:2490168. doi: 10.1155/2016/2490168. Epub 2016 Sep 26. PMID: 27752376; PMCID: PMC5056304.
Copy Download .nbib Format: NLM
Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?.

Mediterranean journal of rheumatology

Sachinidis A, Garyfallos A.
PMID: 34964023
Mediterr J Rheumatol. 2021 Sep 30;32(3):192-199. doi: 10.31138/mjr.32.3.192. eCollection 2021 Sep.

Double Negative (DN) B cells constitute a B cell population that lacks expression of immunoglobulin D and CD27 memory marker. These cells expand in elderly healthy individuals, but also accumulate prematurely in autoimmune and infectious diseases. COVID-19 is a...

Cite
Sachinidis A, Garyfallos A. Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?. Mediterr J Rheumatol. 2021;32(3):192-199doi: 10.31138/mjr.32.3.192.
Sachinidis, A., & Garyfallos, A. (2021). Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?. Mediterranean journal of rheumatology, 32(3), 192-199. https://doi.org/10.31138/mjr.32.3.192
Sachinidis, Athanasios, and Garyfallos, Alexandros. "Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?." Mediterranean journal of rheumatology vol. 32,3 (2021): 192-199. doi: https://doi.org/10.31138/mjr.32.3.192
Sachinidis A, Garyfallos A. Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?. Mediterr J Rheumatol. 2021 Sep 30;32(3):192-199. doi: 10.31138/mjr.32.3.192. eCollection 2021 Sep. PMID: 34964023; PMCID: PMC8693305.
Copy Download .nbib Format: NLM
Spatio-temporal expression of blunt snout bream (Megalobrama amblycephala) mIgD and its immune response to Aeromonas hydrophila.

Central-European journal of immunology

Xia H, Wu K, Liu W, Wang W, Zhang X.
PMID: 26557025
Cent Eur J Immunol. 2015;40(2):132-41. doi: 10.5114/ceji.2015.52825. Epub 2015 Aug 03.

The function of IgD in fish and mammals has not been fully understood since its discovery. In this study, we have isolated and characterized the cDNA that encodes membrane-bound form of the immunoglobulin D heavy chain gene (mIgD) of...

Cite
Xia H, Wu K, Liu W, et al. Spatio-temporal expression of blunt snout bream (Megalobrama amblycephala) mIgD and its immune response to Aeromonas hydrophila. Cent Eur J Immunol. 2015;40(2):132-41doi: 10.5114/ceji.2015.52825.
Xia, H., Wu, K., Liu, W., Wang, W., & Zhang, X. (2015). Spatio-temporal expression of blunt snout bream (Megalobrama amblycephala) mIgD and its immune response to Aeromonas hydrophila. Central-European journal of immunology, 40(2), 132-41. https://doi.org/10.5114/ceji.2015.52825
Xia, Hu, et al. "Spatio-temporal expression of blunt snout bream (Megalobrama amblycephala) mIgD and its immune response to Aeromonas hydrophila." Central-European journal of immunology vol. 40,2 (2015): 132-41. doi: https://doi.org/10.5114/ceji.2015.52825
Xia H, Wu K, Liu W, Wang W, Zhang X. Spatio-temporal expression of blunt snout bream (Megalobrama amblycephala) mIgD and its immune response to Aeromonas hydrophila. Cent Eur J Immunol. 2015;40(2):132-41. doi: 10.5114/ceji.2015.52825. Epub 2015 Aug 03. PMID: 26557025; PMCID: PMC4637386.
Copy Download .nbib Format: NLM
An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma.

Cureus

Sharma A, Binazir T, Sintow A, Lee CC, Shaharyar S, Tache J.
PMID: 28845377
Cureus. 2017 Jun 27;9(6):e1400. doi: 10.7759/cureus.1400.

Multiple myelomas (MM) of the immunoglobulin D (IgD) subtype is rare amongst plasma cell malignancies. It can present a diagnostic challenge because of the low amount of immunoglobulin in the serum. The amount of monoclonal (M)-protein is often undetectable...

Cite
Sharma A, Binazir T, Sintow A, et al. An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma. Cureus. 2017;9(6):e1400doi: 10.7759/cureus.1400.
Sharma, A., Binazir, T., Sintow, A., Lee, C. C., Shaharyar, S., & Tache, J. (2017). An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma. Cureus, 9(6), e1400. https://doi.org/10.7759/cureus.1400
Sharma, Ashish, et al. "An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma." Cureus vol. 9,6 (2017): e1400. doi: https://doi.org/10.7759/cureus.1400
Sharma A, Binazir T, Sintow A, Lee CC, Shaharyar S, Tache J. An Extremely Rare Manifestation of Multiple Myeloma: An Immunoglobulin D Secreting Testicular Plasmacytoma. Cureus. 2017 Jun 27;9(6):e1400. doi: 10.7759/cureus.1400. PMID: 28845377; PMCID: PMC5572044.
Copy Download .nbib Format: NLM
Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants.

British journal of haematology

Shankar AG, Kirkwood AA, Hall GW, Hayward J, O'Hare P, Ramsay AD.
PMID: 26115355
Br J Haematol. 2015 Oct;171(2):254-262. doi: 10.1111/bjh.13540. Epub 2015 Jun 26.

Nodular lymphocyte predominant Hodgkin lymphoma (nLPHL) comprises approximately 10-12% of all childhood Hodgkin lymphoma. As the majority have low stage disease recent years have seen a de-escalation of treatment intensity to avoid treatment-related morbidity. This report evaluates treatment outcome...

Cite
Shankar AG, Kirkwood AA, Hall GW, et al. Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants. Br J Haematol. 2015;171(2):254-262doi: 10.1111/bjh.13540.
Shankar, A. G., Kirkwood, A. A., Hall, G. W., Hayward, J., O'Hare, P., & Ramsay, A. D. (2015). Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants. British journal of haematology, 171(2), 254-262. https://doi.org/10.1111/bjh.13540
Shankar, Ananth G, et al. "Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants." British journal of haematology vol. 171,2 (2015): 254-262. doi: https://doi.org/10.1111/bjh.13540
Shankar AG, Kirkwood AA, Hall GW, Hayward J, O'Hare P, Ramsay AD. Childhood and Adolescent nodular lymphocyte predominant Hodgkin lymphoma - A review of clinical outcome based on the histological variants. Br J Haematol. 2015 Oct;171(2):254-262. doi: 10.1111/bjh.13540. Epub 2015 Jun 26. PMID: 26115355.
Copy Download .nbib Format: NLM
CP-25 Attenuates the Activation of CD4.

Frontiers in pharmacology

Wu YJ, Chen HS, Chen WS, Dong J, Dong XJ, Dai X, Huang Q, Wei W.
PMID: 29410624
Front Pharmacol. 2018 Jan 23;9:4. doi: 10.3389/fphar.2018.00004. eCollection 2018.

Researchers have shown that the level of immunoglobulin D (IgD) is often elevated in patients with autoimmune diseases. The possible roles of IgD on the function of human T cell activation are still unclear. Paeoniflorin-6'-

Cite
Wu YJ, Chen HS, Chen WS, et al. CP-25 Attenuates the Activation of CD4. Front Pharmacol. 2018;9:4doi: 10.3389/fphar.2018.00004.
Wu, Y. J., Chen, H. S., Chen, W. S., Dong, J., Dong, X. J., Dai, X., Huang, Q., & Wei, W. (2018). CP-25 Attenuates the Activation of CD4. Frontiers in pharmacology, 94. https://doi.org/10.3389/fphar.2018.00004
Wu, Yu-Jing, et al. "CP-25 Attenuates the Activation of CD4." Frontiers in pharmacology vol. 9 (2018): 4. doi: https://doi.org/10.3389/fphar.2018.00004
Wu YJ, Chen HS, Chen WS, Dong J, Dong XJ, Dai X, Huang Q, Wei W. CP-25 Attenuates the Activation of CD4. Front Pharmacol. 2018 Jan 23;9:4. doi: 10.3389/fphar.2018.00004. eCollection 2018. PMID: 29410624; PMCID: PMC5787084.
Copy Download .nbib Format: NLM
An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis.

Acta pharmacologica Sinica

Hu XX, Zhang AJ, Pan WW, Xin QL, Chen JY, Zhang LL, Chang Y, Wu YJ, Wei W.
PMID: 33864023
Acta Pharmacol Sin. 2021 Apr 16; doi: 10.1038/s41401-021-00665-w. Epub 2021 Apr 16.

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease characterized by synovitis and the destruction of small joints. Emerging evidence shows that immunoglobulin D (IgD) stimulation induces T-cell activation, which may contribute to diseases pathogenesis in RA. In this...

Cite
Hu XX, Zhang AJ, Pan WW, et al. An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis. Acta Pharmacol Sin. 2021;doi: 10.1038/s41401-021-00665-w.
Hu, X. X., Zhang, A. J., Pan, W. W., Xin, Q. L., Chen, J. Y., Zhang, L. L., Chang, Y., Wu, Y. J., & Wei, W. (2021). An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis. Acta pharmacologica Sinica, . https://doi.org/10.1038/s41401-021-00665-w
Hu, Xiao-Xi, et al. "An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis." Acta pharmacologica Sinica vol. (2021). doi: https://doi.org/10.1038/s41401-021-00665-w
Hu XX, Zhang AJ, Pan WW, Xin QL, Chen JY, Zhang LL, Chang Y, Wu YJ, Wei W. An IgD-Fc-Ig fusion protein restrains the activation of T and B cells by inhibiting IgD-IgDR-Lck signaling in rheumatoid arthritis. Acta Pharmacol Sin. 2021 Apr 16; doi: 10.1038/s41401-021-00665-w. Epub 2021 Apr 16. PMID: 33864023.
Copy Download .nbib Format: NLM
A research standard for human serum immunoglobulin D.

Bulletin of the World Health Organization

Rowe DS, Anderson SG, Tackett L.
PMID: 5313075
Bull World Health Organ. 1970;43(4):607-9.
Free PMC Article

No abstract available.

Cite
Rowe DS, Anderson SG, Tackett L. A research standard for human serum immunoglobulin D. Bull World Health Organ. 1970;43(4):607-9
Rowe, D. S., Anderson, S. G., & Tackett, L. (1970). A research standard for human serum immunoglobulin D. Bulletin of the World Health Organization, 43(4), 607-9.
Rowe, D S, et al. "A research standard for human serum immunoglobulin D." Bulletin of the World Health Organization vol. 43,4 (1970): 607-9.
Rowe DS, Anderson SG, Tackett L. A research standard for human serum immunoglobulin D. Bull World Health Organ. 1970;43(4):607-9. PMID: 5313075; PMCID: PMC2427771.
Copy Download .nbib Format: NLM
Four immunoglobulin isotypes and IgD splice variants in urodele amphibians.

Developmental and comparative immunology

Yoshinaga K, Oshio H, Prasetio B, Hayashida H, Maeda E, Matsumoto M.
PMID: 33301796
Dev Comp Immunol. 2021 Mar;116:103963. doi: 10.1016/j.dci.2020.103963. Epub 2020 Dec 07.

Until recently, different families of urodele amphibians were thought to express distinct subsets of immunoglobulin (Ig) isotypes. In this study, we explored cDNAs encoding Ig heavy-chains (H-chains) in three species of urodele amphibians. We found that Cynops pyrrhogaster, Pleurodeles...

Cite
Yoshinaga K, Oshio H, Prasetio B, et al. Four immunoglobulin isotypes and IgD splice variants in urodele amphibians. Dev Comp Immunol. 2020;116:103963doi: 10.1016/j.dci.2020.103963.
Yoshinaga, K., Oshio, H., Prasetio, B., Hayashida, H., Maeda, E., & Matsumoto, M. (2021). Four immunoglobulin isotypes and IgD splice variants in urodele amphibians. Developmental and comparative immunology, 116103963. https://doi.org/10.1016/j.dci.2020.103963
Yoshinaga, Keisuke, et al. "Four immunoglobulin isotypes and IgD splice variants in urodele amphibians." Developmental and comparative immunology vol. 116 (2021): 103963. doi: https://doi.org/10.1016/j.dci.2020.103963
Yoshinaga K, Oshio H, Prasetio B, Hayashida H, Maeda E, Matsumoto M. Four immunoglobulin isotypes and IgD splice variants in urodele amphibians. Dev Comp Immunol. 2021 Mar;116:103963. doi: 10.1016/j.dci.2020.103963. Epub 2020 Dec 07. PMID: 33301796.
Copy Download .nbib Format: NLM
[Immunoglobulin D multiple myeloma with elevated creatine kinase and numb chin syndrome: a case report].

Zhonghua zhong liu za zhi [Chinese journal of oncology]

Liu L, Dong WH, Du YH, Song XF, Yuan CL, Li Z.
PMID: 29151296
Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):879-880. doi: 10.3760/cma.j.issn.0253-3766.2017.11.012.

No abstract available.

Cite
Liu L, Dong WH, Du YH, et al. [Immunoglobulin D multiple myeloma with elevated creatine kinase and numb chin syndrome: a case report]. Zhonghua Zhong Liu Za Zhi. 2017;39(11):879-880doi: 10.3760/cma.j.issn.0253-3766.2017.11.012.
Liu, L., Dong, W. H., Du, Y. H., Song, X. F., Yuan, C. L., & Li, Z. (2017). [Immunoglobulin D multiple myeloma with elevated creatine kinase and numb chin syndrome: a case report]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 39(11), 879-880. https://doi.org/10.3760/cma.j.issn.0253-3766.2017.11.012
Liu, L, et al. "[Immunoglobulin D multiple myeloma with elevated creatine kinase and numb chin syndrome: a case report]." Zhonghua zhong liu za zhi [Chinese journal of oncology] vol. 39,11 (2017): 879-880. doi: https://doi.org/10.3760/cma.j.issn.0253-3766.2017.11.012
Liu L, Dong WH, Du YH, Song XF, Yuan CL, Li Z. [Immunoglobulin D multiple myeloma with elevated creatine kinase and numb chin syndrome: a case report]. Zhonghua Zhong Liu Za Zhi. 2017 Nov 23;39(11):879-880. doi: 10.3760/cma.j.issn.0253-3766.2017.11.012. Chinese. PMID: 29151296.
Copy Download .nbib Format: NLM
The therapeutic implications of activated immune responses via the enigmatic immunoglobulin D.

International reviews of immunology

Nguyen TG.
PMID: 33410368
Int Rev Immunol. 2021 Jan 07;1-24. doi: 10.1080/08830185.2020.1861265. Epub 2021 Jan 07.

Immunoglobulin D (IgD) is an enigmatic antibody and the least appreciated member of the immunoglobulin (Ig) family. Since its discovery over half a century ago, the essence of its function in the immune system has been somewhat enigmatic and...

Cite
Nguyen TG. The therapeutic implications of activated immune responses via the enigmatic immunoglobulin D. Int Rev Immunol. 2021;1-24doi: 10.1080/08830185.2020.1861265.
Nguyen, T. G. (2021). The therapeutic implications of activated immune responses via the enigmatic immunoglobulin D. International reviews of immunology, 1-24. https://doi.org/10.1080/08830185.2020.1861265
Nguyen, Tue Gia. "The therapeutic implications of activated immune responses via the enigmatic immunoglobulin D." International reviews of immunology vol. (2021): 1-24. doi: https://doi.org/10.1080/08830185.2020.1861265
Nguyen TG. The therapeutic implications of activated immune responses via the enigmatic immunoglobulin D. Int Rev Immunol. 2021 Jan 07;1-24. doi: 10.1080/08830185.2020.1861265. Epub 2021 Jan 07. PMID: 33410368.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 26 entries